Adaptimmune Therapeutics plc
ADAP
$0.2223
$0.00733.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.18% | 15.06% | 4.93% | -13.23% | -28.18% |
| Total Receivables | -65.94% | -9.56% | -41.93% | -24.83% | 23.19% |
| Inventory | 455.23% | 52.79% | -4.20% | 27.33% | 3.91% |
| Prepaid Expenses | 0.79% | 18.30% | -18.32% | 45.19% | 5.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.43% | 100.53% | 86.23% | 70.49% | 25.17% |
| Total Current Assets | -9.34% | 11.33% | -3.06% | -12.56% | -18.72% |
|
|
|||||
| Total Current Assets | -9.34% | 11.33% | -3.06% | -12.56% | -18.72% |
| Net Property, Plant & Equipment | -28.57% | -11.62% | -17.35% | -6.34% | 0.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1,075.76% | 1,015.36% | 115.12% | 18.28% | -25.34% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.91% | 21.11% | -11.30% | 81.12% | 92.86% |
| Total Assets | -12.97% | 7.01% | -6.20% | -10.44% | -14.08% |
|
|
|||||
| Total Accounts Payable | 6.94% | -34.86% | -48.94% | 26.99% | 71.01% |
| Total Accrued Expenses | 7.09% | 13.37% | 22.55% | -26.38% | -0.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.54% | -17.83% | 11.38% | 84.73% | 97.36% |
| Total Finance Division Other Current Liabilities | -33.51% | -32.36% | 22.02% | 27.83% | 8.81% |
| Total Other Current Liabilities | -33.51% | -32.36% | 22.02% | 27.83% | 8.81% |
| Total Current Liabilities | -11.35% | -15.56% | 7.81% | 4.37% | 12.85% |
|
|
|||||
| Total Current Liabilities | -11.35% | -15.56% | 7.81% | 4.37% | 12.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.96% | -0.32% | -20.79% | -7.75% | -2.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -33.48% | -8.13% | -14.60% | 23.39% | -7.23% |
| Total Liabilities | -3.70% | 13.88% | 4.20% | 14.41% | -1.59% |
|
|
|||||
| Common Stock & APIC | 3.87% | 3.91% | 4.01% | 10.55% | 7.50% |
| Retained Earnings | -6.92% | -4.56% | -7.80% | -17.99% | -12.52% |
| Treasury Stock & Other | 49.25% | -5,135.29% | -10.35% | -52.38% | -328.34% |
| Total Common Equity | -70.01% | -9.24% | -23.98% | -70.94% | -51.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -70.01% | -9.24% | -23.98% | -70.94% | -51.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -70.01% | -9.24% | -23.98% | -70.94% | -51.74% |
|
|
|||||
